Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment

At EADV 2024, Sascha D. W. Stave presents a study that investigates patient preferences in atopic dermatitis treatment. Results show that safety is the top priority for patients, with many favoring treatments with fewer side effects, even if they take longer to show results. The study underscores the need for clinicians to emphasize safety in treatment discussions and for pharmaceutical companies to develop safer treatment options.